Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Sublingual Film for Hyperadrenergic Autonomic Crisis in Familial Dysautonomia
NCT06128356Phase 2Active, not recruiting
- Sponsor
- NYU Langone Health
- Start
- Jun 2024
- Primary completion
- Sep 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dexmedetomidine in Familial dysautonomia (FD), sponsored by NYU Langone Health. Started Jun 2024; status: active, not recruiting.
02
Drugs
dexmedetomidine
03
Conditions
Familial dysautonomia (FD)
Beyond the preview
Go deeper on NCT06128356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06128356.